Azetidine and pyrrolidine PARP1 inhibitors and uses thereof
MYPI2025006356A0Undetermined Publication Date: 2023-04-01XINTHERA INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025006356
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-08-31
- Filing Date
- 2022-09-30
- Publication Date
- 2023-04-01
Abstract
Described herein are azetidine and pyrrolidine PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.
Need to check novelty before this filing date? Find Prior Art
